About Us

Morning Market Losers

By: via Benzinga
Aerie Pharmaceuticals Inc (NASDAQ: AERI) shares dipped 57.08 percent to $15.19 following an announcement of a failed Phase 3 drug ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.